Prijeđi na sadržaj

Buspiron

Izvor: Wikipedija
Buspiron
(IUPAC) ime
8-[4-(4-pirimidin-2-ilpiperazin-1-il)butil]-8-azaspiro[4.5]dekan-7,9-dion
Klinički podaci
Robne marke Buspar
AHFS/Drugs.com Monografija
MedlinePlus a688005
Identifikatori
CAS broj 36505-84-7
ATC kod N05BE01
PubChem[1][2] 2477
DrugBank DB00490
ChemSpider[3] 2383
UNII TK65WKS8HL 
KEGG[4] D07593 
ChEBI CHEBI:3223 
ChEMBL[5] CHEMBL49 
Hemijski podaci
Formula C21H31N5O2 
Mol. masa 385,50314 g/mol
SMILES eMolekuli & PubHem
Farmakokinetički podaci
Bioraspoloživost 5%
Vezivanje za proteine plazme 95%
Metabolizam Hepatic
Poluvreme eliminacije 2-3 sata
Izlučivanje Urin (29-63%), izmet (18-38%)
Farmakoinformacioni podaci
Trudnoća B(US)
Pravni status ℞ Prescription only
Način primene Oralno

Buspiron (Buspar) je anksiolitički psihoaktivni lek iz azapironske hemijske klase. On se prvenstveno koristi za tretiranje generalizovanog anksioznog poremećaja.

Medicinska upotreba

[uredi | uredi kod]

Hemija

[uredi | uredi kod]

Sinteza buspirona počinje sa N-alkilacijom 1-(2-pirimidil)piperazina sa 4-hlorobutironitrilom čemu sledi hidrogenacija nitrila preko Ranejev nikal katalizatora. Primarni aminski produkt prethodnog koraka sa spirocikličnim kiselim anhidridom daje buspiron.[10]

Reference

[uredi | uredi kod]
  1. ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
  2. ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
  3. ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
  4. ↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
  5. ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
  6. ↑ „Buspirone monograph”. Drugs.com. Pristupljeno 27. 8. 2011.
  7. ↑ National Institute Of Health. „Questions and Answers about the NIMH Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study — All Medication Levels”. Arhivirano iz originala na datum 2012-08-19. Pristupljeno 12. 8. 2012.
  8. ↑ Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ (March 2006). „Medication augmentation after the failure of SSRIs for depression”. N. Engl. J. Med. 354 (12): 1243–52. DOI:10.1056/NEJMoa052964. PMID 16554526.
  9. ↑ Appelberg BG, Syvälahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH (June 2001). „Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors and in a Class of Drugs called Benzodiazepines and effects similar if not idenical to Alprazelam,Lorazepam etc : results from a placebo-controlled, randomized, double-blind, placebo wash-in study”. J Clin Psychiatry 62 (6): 448–52. PMID 11465522.
  10. ↑ Wu YH, Rayburn JW, Allen LE, Ferguson HC, Kissel JW (May 1972). „Psychosedative agents. 2. 8-(4-Substituted 1-piperazinylalkyl)-8-azaspiro(4.5)decane-7,9-diones”. J. Med. Chem. 15 (5): 477–9. DOI:10.1021/jm00275a009. PMID 5035267.;
    DE 2057845, Šablon:Cite patent/authors, "Heterocyclische Azaspirodecandione und Verfahren zu ihrer Herstellung", published 9. 6. 1971.;
    US 3717634, Šablon:Cite patent/authors, "N-(heteroarcyclic)piperazinylalkyl-azaspiroalkanediones", published 20. 2. 1973.;
    US 3907801, Šablon:Cite patent/authors, "N8 (4-pyridyl-piperazino)-alkyl9-azaspiroalkanediones", published 23. 9. 1975.;
    US 3976776, Šablon:Cite patent/authors, "Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones", published 24. 8. 1976.

Povezano

[uredi | uredi kod]

Vanjske veze

[uredi | uredi kod]